Advanced search
1 file | 57.47 KB

Are gadolinium enhanced T1 MR sequences mandatory in the follow up of RRMS patients treated with natalizumab

(2015) JOURNAL OF THE NEUROLOGICAL SCIENCES. 357(suppl. 1). p.e318-e318
Author
Organization

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 57.47 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Seynaeve, Patrick, PHILIP WINNOCK-DE GRAVE, Eveline Claus, P Vanderdonckt, P Bourgeois, P Mortele, O Vanovermeire, and Koenraad Verstraete. 2015. “Are Gadolinium Enhanced T1 MR Sequences Mandatory in the Follow up of RRMS Patients Treated with Natalizumab.” In Journal of the Neurological Sciences, 357:e318–e318.
APA
Seynaeve, P., WINNOCK-DE GRAVE, P., Claus, E., Vanderdonckt, P., Bourgeois, P., Mortele, P., Vanovermeire, O., et al. (2015). Are gadolinium enhanced T1 MR sequences mandatory in the follow up of RRMS patients treated with natalizumab. JOURNAL OF THE NEUROLOGICAL SCIENCES (Vol. 357, pp. e318–e318). Presented at the 22nd World congress of Neurology (WCN 2015).
Vancouver
1.
Seynaeve P, WINNOCK-DE GRAVE P, Claus E, Vanderdonckt P, Bourgeois P, Mortele P, et al. Are gadolinium enhanced T1 MR sequences mandatory in the follow up of RRMS patients treated with natalizumab. JOURNAL OF THE NEUROLOGICAL SCIENCES. 2015. p. e318–e318.
MLA
Seynaeve, Patrick, PHILIP WINNOCK-DE GRAVE, Eveline Claus, et al. “Are Gadolinium Enhanced T1 MR Sequences Mandatory in the Follow up of RRMS Patients Treated with Natalizumab.” Journal of the Neurological Sciences. Vol. 357. 2015. e318–e318. Print.
@inproceedings{8040574,
  articleno    = {abstract 1045},
  author       = {Seynaeve, Patrick and WINNOCK-DE GRAVE, PHILIP and Claus, Eveline and Vanderdonckt, P and Bourgeois, P and Mortele, P and Vanovermeire, O and Verstraete, Koenraad},
  booktitle    = {JOURNAL OF THE NEUROLOGICAL SCIENCES},
  issn         = {0022-510X},
  language     = {eng},
  location     = {Santiago, Chile},
  number       = {suppl. 1},
  pages        = {abstract 1045:e318--abstract 1045:e318},
  title        = {Are gadolinium enhanced T1 MR sequences mandatory in the follow up of RRMS patients treated with natalizumab},
  url          = {http://dx.doi.org/10.1016/j.jns.2015.08.1142},
  volume       = {357},
  year         = {2015},
}

Altmetric
View in Altmetric
Web of Science
Times cited: